- ►diabetesjournals.org JL Gross, MJ de Azevedo, SP Silveiro, LH … - Diabetes Care, 2005 - Am Diabetes Assoc Diabetic nephropathy is the leading cause of kidney disease in patients starting
renal replacement therapy and affects ∼40% of type 1 and type 2 diabetic
patients. It increases the risk of death, mainly from cardiovascular ... Cited by 214 - Related articles - All 18 versions
GS Meneilly - Medical Clinics of North America, 2006 - Elsevier Numerous studies over the last decade have evaluated the incidence and
prevalence of diabetes in the elderly. Although differing diagnostic criteria
have been used, these studies consistently found an increased prevalence of ... Cited by 76 - Related articles - BL Direct - All 7 versions
BJ Zarowitz, EG Tangalos, K Hollenack, TO' … - Journal of the American Medical Directors Association, 2006 - Elsevier Despite these staggering statistics, diabetes remains under-diagnosed in as many
as 33% of patients and fewer than 56% of treated diabetics achieve target A1c
values of less than 8% in the United States. 8 and 9 In community-dwelling ... Cited by 19 - Related articles - BL Direct - All 4 versions
RE Pratley, J Rosenstock, FX Pi-Sunyer, MA … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—Mean baseline A1C and fasting plasma glucose (FPG) were significantly
lower in older (70 years: 8.3 ± 0.1% and 9.6 ± 0.1 mmol/l, respectively) than
in younger (50 years: 8.7 ± 0.0% and 10.5 ± 0.1 mmol/l, respectively) ... Cited by 20 - Related articles - BL Direct - All 5 versions
IW Campbell - International Journal of Clinical Practice, 2005 - medscape.com Therapy for type 2 diabetes mellitus should aim to control not only fasting, but
also postprandial glucose levels. Nateglinide, a d-phenylalanine derivative,
restores postprandial early phase insulin secretion in a transient and ... Cited by 15 - Related articles - BL Direct - All 6 versions
JF Blickle - Diabetes and Metabolism, 2006 - Elsevier Glinides represent a chemically heterogeneous new class of insulinsecreting
agents characterized by a rapid onset and short duration of action. They act by
closure of the ATP-dependant K channel. Repaglinide, the only glinide ... Cited by 16 - Related articles - BL Direct - All 3 versions
C Mathieu, K Bollaerts - International Journal of Clinical Practice-Supplement, 2007 - interscience.wiley.com Management of elderly patients with type II diabetes is complicated by
age-related changes in physiology, comorbidities, polypharmacy and heterogeneity
of functional status. A minimum goal in antidiabetic treatment in this ... Cited by 7 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org PS Odegard, SM Setter, JJ Neumiller - Diabetes Spectrum, 2007 - Am Diabetes Assoc More than 20 million people in America are estimated to have diabetes, with the
prevalence in adults > 60 years of age now > 20%. 1 The increased prevalence in
older adults may be the result of several factors, including physiological ... Cited by 4 - Related articles - BL Direct - All 2 versions
JL Gross, SP Silveiro, LH Canani, R Friedman … - Arquivos Brasileiros de Endocrinologia & Metabologia, 2007 - SciELO Brasil Pacientes em diferentes estágios de nefropatia diabética (ND) apresentam
freqüentemente comprometimento cardíaco expresso por isquemia miocárdica e/ou
cardiomiopatia diabética. Estas alterações já estão presentes em ... Cited by 6 - Related articles - Cached - All 3 versions
SL Schwarz, JE Gerich, A Marcellari, L Jean- … - Diabetes Obes Metab, 2008 - interscience.wiley.com Methods: Study 1 was a 12-week, multicentre, randomized, double blind and
placebo-controlled study of nateglinide monotherapy (120 mg, before meals) in 66
drug-naïve patients with T2DM aged ≥65 years. Study 2 was a 104-week, ... Cited by 2 - Related articles - All 3 versions
